Hamed Tewfik practices Radiation Oncology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Hamed Tewfik has written publications. He has 43 publications published with PubMed. The lastest paper is: 'Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial.' Hamed Tewfik accepts all Medicare patients.
NPI NUMBER | 1437144144 | |
NPPES Provider LastName | TEWFIK | |
NPPES Provider FirstName | HAMED | |
NPPES Provider ZIPCode | 522459572 | |
NPPES Provider State | IA | |
Specialty Description | Radiation Oncology | |
Total Claim Count | 77.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1437144144 |
Last Name Of The Provider | TEWFIK |
First Name Of The Provider | HAMED |
View All |
Dr. Casey E. Duncan, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. William L. McGinnis, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Hani M. Al-Ali, MD | |
Dr. Andrew C. Hoover, MD | |
Dr. Daniel J. Ferraro, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Darrion L. Mitchell, MD | |
Dr. Edwin J. VanBeek Jr., MD | |
Wenqing Sun, MB
This Doctor is OpenDoctor Recommended. |